50ShadesGreyMarket
GLP-1 Enthusiast
I haven’t seen any posts related to Myostatin inhibitors on here. I assume most folks who care about muscle hypertrophy are on HMB or something like that. The trials for Trevagrumab and Garetosmab are in Phase 2b which is usually the point where we start seeing lyophilized vials pop up on the black and then grey market.
Anybody know which door we gotta knock on around here? Considering we have sources for oils, I would assume a peptide that blocks Activin A and ActRII would be extremely popular.
Anybody know which door we gotta knock on around here? Considering we have sources for oils, I would assume a peptide that blocks Activin A and ActRII would be extremely popular.